October 28th 2024
The significance of antiretroviral therapy (ART) has been a game changer for people living with HIV (PLWH). Still, there are some cardiovascular risks associated with different ART classes—particularly protease inhibitors (PIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase strand transfer inhibitors (INSTIs). Authors review a piece in the literature around this area of study.
On-Demand vs. Daily PrEP Effective Even With Lower Sexual Frequency
December 13th 2019An analysis of participants in a trial measuring the efficacy of PrEP found that sex-driven dose timing—as opposed to daily dosing—was effective in preventing HIV, even in men who had sex less often.
Read More
Depression Associated With Higher HIV Incidence for South African Girls
November 22nd 2019A study found that depressive symptoms are associated with higher incidence of HIV transmission for adolescent girls and young women in South Africa, with familial and social factors mediating this association.
Read More
TAF vs. TDF: Measuring Lipid Levels in HIV Treatment
November 22nd 2019TAF causes cholesterol levels to rise, but that includes levels of “good cholesterol” HDL. Researchers concluded that there is no significant difference in cardiovascular risk profiles between people taking TAF and those taking TDF.
Read More